MR-guided HIFU for pain palliation of bone metastases

A new clinical multi-centre trial is underway to assess the effectiveness of pain palliation in bone metastases using the Philips Sonalleve MR-HIFU (high intensity focused ultrasound) system. Researchers at The Royal Marsden and The Institute of Cancer Research (ICR), London, are participating in the trial and this article outlines the clinical context and our experience on the study so far.

The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.

Stay up to date with
RAD Magazine

Sign up for our newsletter.

We care about your data. Read our privacy policy.